nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—mammary gland—breast cancer	0.0178	0.212	CbGeAlD
Lorazepam—UGT2B15—female reproductive system—breast cancer	0.00736	0.0875	CbGeAlD
Lorazepam—UGT2B15—endocrine gland—breast cancer	0.00623	0.0741	CbGeAlD
Lorazepam—TSPO—nipple—breast cancer	0.00527	0.0627	CbGeAlD
Lorazepam—TSPO—embryo—breast cancer	0.00435	0.0517	CbGeAlD
Lorazepam—TSPO—epithelium—breast cancer	0.00355	0.0422	CbGeAlD
Lorazepam—GABRG2—pituitary gland—breast cancer	0.0034	0.0405	CbGeAlD
Lorazepam—TSPO—skin of body—breast cancer	0.00337	0.0401	CbGeAlD
Lorazepam—TSPO—endometrium—breast cancer	0.00318	0.0378	CbGeAlD
Lorazepam—TSPO—uterus—breast cancer	0.00293	0.0349	CbGeAlD
Lorazepam—TSPO—pituitary gland—breast cancer	0.00288	0.0342	CbGeAlD
Lorazepam—TSPO—adipose tissue—breast cancer	0.00287	0.0341	CbGeAlD
Lorazepam—TSPO—female reproductive system—breast cancer	0.00264	0.0314	CbGeAlD
Lorazepam—GABRB3—pituitary gland—breast cancer	0.00261	0.0311	CbGeAlD
Lorazepam—TSPO—adrenal gland—breast cancer	0.00257	0.0306	CbGeAlD
Lorazepam—TSPO—bone marrow—breast cancer	0.00249	0.0296	CbGeAlD
Lorazepam—TSPO—female gonad—breast cancer	0.0024	0.0285	CbGeAlD
Lorazepam—GABRB3—female reproductive system—breast cancer	0.00239	0.0285	CbGeAlD
Lorazepam—TSPO—endocrine gland—breast cancer	0.00223	0.0265	CbGeAlD
Lorazepam—GABRB3—endocrine gland—breast cancer	0.00203	0.0241	CbGeAlD
Lorazepam—Clonazepam—NAT2—breast cancer	0.00188	0.116	CrCbGaD
Lorazepam—Chlorthalidone—CA9—breast cancer	0.00176	0.109	CrCbGaD
Lorazepam—TSPO—lymph node—breast cancer	0.00154	0.0183	CbGeAlD
Lorazepam—Diclofenac—ABCC1—breast cancer	0.00124	0.0766	CrCbGaD
Lorazepam—Diclofenac—CXCL8—breast cancer	0.00109	0.0678	CrCbGaD
Lorazepam—Diclofenac—PTGS1—breast cancer	0.000559	0.0346	CrCbGaD
Lorazepam—Diclofenac—CYP1A1—breast cancer	0.000511	0.0316	CrCbGaD
Lorazepam—Clozapine—CYP1B1—breast cancer	0.000499	0.0309	CrCbGaD
Lorazepam—Chills—Docetaxel—breast cancer	0.000435	0.000575	CcSEcCtD
Lorazepam—Asthenia—Vinorelbine—breast cancer	0.000434	0.000573	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—breast cancer	0.000433	0.000573	CcSEcCtD
Lorazepam—Nausea—Vinblastine—breast cancer	0.000432	0.000571	CcSEcCtD
Lorazepam—Somnolence—Gemcitabine—breast cancer	0.000432	0.000571	CcSEcCtD
Lorazepam—Convulsion—Paclitaxel—breast cancer	0.000432	0.000571	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Irinotecan—breast cancer	0.000431	0.000569	CcSEcCtD
Lorazepam—Hypertension—Paclitaxel—breast cancer	0.00043	0.000569	CcSEcCtD
Lorazepam—Fatigue—Irinotecan—breast cancer	0.00043	0.000568	CcSEcCtD
Lorazepam—Fatigue—Mitoxantrone—breast cancer	0.00043	0.000568	CcSEcCtD
Lorazepam—Vomiting—Goserelin—breast cancer	0.000429	0.000567	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—breast cancer	0.000429	0.000567	CcSEcCtD
Lorazepam—Pain—Mitoxantrone—breast cancer	0.000426	0.000563	CcSEcCtD
Lorazepam—Constipation—Mitoxantrone—breast cancer	0.000426	0.000563	CcSEcCtD
Lorazepam—Pain—Irinotecan—breast cancer	0.000426	0.000563	CcSEcCtD
Lorazepam—Constipation—Irinotecan—breast cancer	0.000426	0.000563	CcSEcCtD
Lorazepam—Rash—Goserelin—breast cancer	0.000426	0.000562	CcSEcCtD
Lorazepam—Hypersensitivity—Thiotepa—breast cancer	0.000425	0.000562	CcSEcCtD
Lorazepam—Dermatitis—Goserelin—breast cancer	0.000425	0.000562	CcSEcCtD
Lorazepam—Somnolence—Fluorouracil—breast cancer	0.000425	0.000561	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CHST9—breast cancer	0.000424	0.00296	CbGpPWpGaD
Lorazepam—Headache—Goserelin—breast cancer	0.000423	0.000559	CcSEcCtD
Lorazepam—Erythema—Docetaxel—breast cancer	0.000422	0.000558	CcSEcCtD
Lorazepam—Chills—Capecitabine—breast cancer	0.000422	0.000557	CcSEcCtD
Lorazepam—Nausea—Tamoxifen—breast cancer	0.00042	0.000555	CcSEcCtD
Lorazepam—Arrhythmia—Capecitabine—breast cancer	0.00042	0.000555	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000419	0.000554	CcSEcCtD
Lorazepam—Fatigue—Gemcitabine—breast cancer	0.000419	0.000553	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—breast cancer	0.000416	0.00055	CcSEcCtD
Lorazepam—Constipation—Gemcitabine—breast cancer	0.000415	0.000549	CcSEcCtD
Lorazepam—Pain—Gemcitabine—breast cancer	0.000415	0.000549	CcSEcCtD
Lorazepam—Alopecia—Capecitabine—breast cancer	0.000415	0.000549	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—breast cancer	0.000415	0.000548	CcSEcCtD
Lorazepam—Dry mouth—Paclitaxel—breast cancer	0.000415	0.000548	CcSEcCtD
Lorazepam—Asthenia—Thiotepa—breast cancer	0.000414	0.000547	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000412	0.000545	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—breast cancer	0.000412	0.000544	CcSEcCtD
Lorazepam—Nausea—Melphalan—breast cancer	0.000411	0.000543	CcSEcCtD
Lorazepam—Feeling abnormal—Irinotecan—breast cancer	0.000411	0.000543	CcSEcCtD
Lorazepam—Feeling abnormal—Mitoxantrone—breast cancer	0.000411	0.000543	CcSEcCtD
Lorazepam—Chlordiazepoxide—CYP2D6—breast cancer	0.000411	0.0254	CrCbGaD
Lorazepam—Confusional state—Paclitaxel—breast cancer	0.00041	0.000542	CcSEcCtD
Lorazepam—Erythema—Capecitabine—breast cancer	0.000409	0.00054	CcSEcCtD
Lorazepam—Pain—Fluorouracil—breast cancer	0.000408	0.00054	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000408	0.00285	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000408	0.00285	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000407	0.00284	CbGpPWpGaD
Lorazepam—Liver function test abnormal—Doxorubicin—breast cancer	0.000404	0.000534	CcSEcCtD
Lorazepam—Infection—Paclitaxel—breast cancer	0.000404	0.000534	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—breast cancer	0.000402	0.000532	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—SQSTM1—breast cancer	0.000402	0.00281	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COX11—breast cancer	0.000402	0.00281	CbGpPWpGaD
Lorazepam—Nausea—Goserelin—breast cancer	0.000401	0.00053	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000401	0.0028	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000401	0.0028	CbGpPWpGaD
Lorazepam—Feeling abnormal—Gemcitabine—breast cancer	0.0004	0.000529	CcSEcCtD
Lorazepam—Dizziness—Vinorelbine—breast cancer	0.0004	0.000528	CcSEcCtD
Lorazepam—Thrombocytopenia—Paclitaxel—breast cancer	0.000398	0.000526	CcSEcCtD
Lorazepam—Tachycardia—Paclitaxel—breast cancer	0.000397	0.000525	CcSEcCtD
Lorazepam—Feeling abnormal—Fluorouracil—breast cancer	0.000394	0.00052	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—breast cancer	0.00039	0.000515	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—breast cancer	0.000388	0.000513	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—RPS6—breast cancer	0.000386	0.0027	CbGpPWpGaD
Lorazepam—Vision blurred—Capecitabine—breast cancer	0.000385	0.000509	CcSEcCtD
Lorazepam—Vomiting—Vinorelbine—breast cancer	0.000384	0.000508	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000384	0.00269	CbGpPWpGaD
Lorazepam—GABRA1—Orphan transporters—NCOA1—breast cancer	0.000384	0.00269	CbGpPWpGaD
Lorazepam—Tremor—Capecitabine—breast cancer	0.000383	0.000506	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000383	0.00268	CbGpPWpGaD
Lorazepam—Dizziness—Thiotepa—breast cancer	0.000382	0.000505	CcSEcCtD
Lorazepam—Rash—Vinorelbine—breast cancer	0.000381	0.000504	CcSEcCtD
Lorazepam—Dermatitis—Vinorelbine—breast cancer	0.000381	0.000503	CcSEcCtD
Lorazepam—Hypotension—Paclitaxel—breast cancer	0.00038	0.000502	CcSEcCtD
Lorazepam—Headache—Vinorelbine—breast cancer	0.000379	0.000501	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—PLG—breast cancer	0.000374	0.00262	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SHMT1—breast cancer	0.000367	0.00257	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CDA—breast cancer	0.000367	0.00257	CbGpPWpGaD
Lorazepam—Vertigo—Capecitabine—breast cancer	0.000367	0.000486	CcSEcCtD
Lorazepam—Hypersensitivity—Mitoxantrone—breast cancer	0.000367	0.000485	CcSEcCtD
Lorazepam—Hypersensitivity—Irinotecan—breast cancer	0.000367	0.000485	CcSEcCtD
Lorazepam—Vomiting—Thiotepa—breast cancer	0.000367	0.000485	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—breast cancer	0.000366	0.000484	CcSEcCtD
Lorazepam—Hypertension—Docetaxel—breast cancer	0.000365	0.000482	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—breast cancer	0.000365	0.000482	CcSEcCtD
Lorazepam—Rash—Thiotepa—breast cancer	0.000364	0.000481	CcSEcCtD
Lorazepam—Dermatitis—Thiotepa—breast cancer	0.000364	0.000481	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—breast cancer	0.000364	0.00048	CcSEcCtD
Lorazepam—Bromazepam—CYP3A4—breast cancer	0.000363	0.0225	CrCbGaD
Lorazepam—Headache—Thiotepa—breast cancer	0.000362	0.000478	CcSEcCtD
Lorazepam—Somnolence—Paclitaxel—breast cancer	0.000362	0.000478	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—breast cancer	0.000359	0.000475	CcSEcCtD
Lorazepam—Nausea—Vinorelbine—breast cancer	0.000359	0.000475	CcSEcCtD
Lorazepam—Asthenia—Irinotecan—breast cancer	0.000358	0.000473	CcSEcCtD
Lorazepam—Asthenia—Mitoxantrone—breast cancer	0.000358	0.000473	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—breast cancer	0.000355	0.00047	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SLC2A5—breast cancer	0.000354	0.00247	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLCO1B1—breast cancer	0.000354	0.00247	CbGpPWpGaD
Lorazepam—Hypertension—Capecitabine—breast cancer	0.000353	0.000467	CcSEcCtD
Lorazepam—Chlordiazepoxide—CYP3A4—breast cancer	0.000352	0.0218	CrCbGaD
Lorazepam—Hypersensitivity—Fluorouracil—breast cancer	0.000352	0.000465	CcSEcCtD
Lorazepam—Dry mouth—Docetaxel—breast cancer	0.000352	0.000465	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000351	0.000464	CcSEcCtD
Lorazepam—Fatigue—Paclitaxel—breast cancer	0.000351	0.000463	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00035	0.00245	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00035	0.00245	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—EGR1—breast cancer	0.00035	0.00245	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ACHE—breast cancer	0.000349	0.00244	CbGpPWpGaD
Lorazepam—Asthenia—Gemcitabine—breast cancer	0.000349	0.000461	CcSEcCtD
Lorazepam—Pain—Paclitaxel—breast cancer	0.000348	0.00046	CcSEcCtD
Lorazepam—Constipation—Paclitaxel—breast cancer	0.000348	0.00046	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—breast cancer	0.000348	0.000459	CcSEcCtD
Lorazepam—Nausea—Thiotepa—breast cancer	0.000343	0.000453	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ACHE—breast cancer	0.000343	0.0024	CbGpPWpGaD
Lorazepam—Infection—Docetaxel—breast cancer	0.000342	0.000453	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—APRT—breast cancer	0.000342	0.00239	CbGpPWpGaD
Lorazepam—Dry mouth—Capecitabine—breast cancer	0.00034	0.00045	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—breast cancer	0.00034	0.00045	CcSEcCtD
Lorazepam—Clonazepam—CYP3A4—breast cancer	0.00034	0.0211	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—COX11—breast cancer	0.000338	0.00237	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000338	0.00237	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Docetaxel—breast cancer	0.000338	0.000446	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—breast cancer	0.000337	0.000446	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—breast cancer	0.000337	0.000445	CcSEcCtD
Lorazepam—Confusional state—Capecitabine—breast cancer	0.000337	0.000445	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—breast cancer	0.000336	0.000445	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000336	0.00235	CbGpPWpGaD
Lorazepam—Feeling abnormal—Paclitaxel—breast cancer	0.000335	0.000443	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—breast cancer	0.000333	0.00044	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000332	0.00232	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—COX11—breast cancer	0.000332	0.00232	CbGpPWpGaD
Lorazepam—Infection—Capecitabine—breast cancer	0.000332	0.000438	CcSEcCtD
Lorazepam—Dizziness—Irinotecan—breast cancer	0.00033	0.000436	CcSEcCtD
Lorazepam—Clorazepate—CYP3A4—breast cancer	0.000329	0.0204	CrCbGaD
Lorazepam—Jaundice—Doxorubicin—breast cancer	0.000329	0.000434	CcSEcCtD
Lorazepam—Thrombocytopenia—Capecitabine—breast cancer	0.000327	0.000432	CcSEcCtD
Lorazepam—Diclofenac—CYP3A4—breast cancer	0.000326	0.0202	CrCbGaD
Lorazepam—Tachycardia—Capecitabine—breast cancer	0.000326	0.00043	CcSEcCtD
Lorazepam—Hypotension—Docetaxel—breast cancer	0.000322	0.000426	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ESRRA—breast cancer	0.000321	0.00225	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ANGPTL4—breast cancer	0.000321	0.00225	CbGpPWpGaD
Lorazepam—Diclofenac—PTGS2—breast cancer	0.000319	0.0198	CrCbGaD
Lorazepam—Vomiting—Mitoxantrone—breast cancer	0.000317	0.000419	CcSEcCtD
Lorazepam—Vomiting—Irinotecan—breast cancer	0.000317	0.000419	CcSEcCtD
Lorazepam—Clotiazepam—CYP3A4—breast cancer	0.000316	0.0196	CrCbGaD
Lorazepam—Dizziness—Fluorouracil—breast cancer	0.000316	0.000417	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—breast cancer	0.000315	0.000417	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—breast cancer	0.000315	0.000416	CcSEcCtD
Lorazepam—Rash—Irinotecan—breast cancer	0.000314	0.000415	CcSEcCtD
Lorazepam—Rash—Mitoxantrone—breast cancer	0.000314	0.000415	CcSEcCtD
Lorazepam—Dermatitis—Mitoxantrone—breast cancer	0.000314	0.000415	CcSEcCtD
Lorazepam—Dermatitis—Irinotecan—breast cancer	0.000314	0.000415	CcSEcCtD
Lorazepam—Chills—Methotrexate—breast cancer	0.000314	0.000415	CcSEcCtD
Lorazepam—Headache—Mitoxantrone—breast cancer	0.000312	0.000413	CcSEcCtD
Lorazepam—Headache—Irinotecan—breast cancer	0.000312	0.000413	CcSEcCtD
Lorazepam—Hypotension—Capecitabine—breast cancer	0.000312	0.000412	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000309	0.00216	CbGpPWpGaD
Lorazepam—Alopecia—Methotrexate—breast cancer	0.000309	0.000408	CcSEcCtD
Lorazepam—Vomiting—Gemcitabine—breast cancer	0.000309	0.000408	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—breast cancer	0.000308	0.000407	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—STAT5A—breast cancer	0.000307	0.00215	CbGpPWpGaD
Lorazepam—Somnolence—Docetaxel—breast cancer	0.000306	0.000405	CcSEcCtD
Lorazepam—Rash—Gemcitabine—breast cancer	0.000306	0.000405	CcSEcCtD
Lorazepam—Dermatitis—Gemcitabine—breast cancer	0.000306	0.000404	CcSEcCtD
Lorazepam—Amoxapine—CYP2D6—breast cancer	0.000306	0.0189	CrCbGaD
Lorazepam—UGT2B15—Metabolism—HADHB—breast cancer	0.000304	0.00213	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPI—breast cancer	0.000304	0.00213	CbGpPWpGaD
Lorazepam—Erythema—Methotrexate—breast cancer	0.000304	0.000402	CcSEcCtD
Lorazepam—Headache—Gemcitabine—breast cancer	0.000304	0.000402	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BCHE—breast cancer	0.000304	0.00212	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000304	0.00212	CbGpPWpGaD
Lorazepam—Vomiting—Fluorouracil—breast cancer	0.000304	0.000401	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000301	0.00211	CbGpPWpGaD
Lorazepam—Rash—Fluorouracil—breast cancer	0.000301	0.000398	CcSEcCtD
Lorazepam—Dermatitis—Fluorouracil—breast cancer	0.000301	0.000398	CcSEcCtD
Lorazepam—Hypersensitivity—Paclitaxel—breast cancer	0.0003	0.000396	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ACHE—breast cancer	0.000299	0.00209	CbGpPWpGaD
Lorazepam—Headache—Fluorouracil—breast cancer	0.000299	0.000395	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BCHE—breast cancer	0.000298	0.00209	CbGpPWpGaD
Lorazepam—Alprazolam—CYP3A4—breast cancer	0.000298	0.0185	CrCbGaD
Lorazepam—Diazepam—PTGS1—breast cancer	0.000298	0.0185	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000298	0.00208	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000298	0.00208	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Docetaxel—breast cancer	0.000298	0.000393	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—breast cancer	0.000297	0.000393	CcSEcCtD
Lorazepam—Clonazepam—ALB—breast cancer	0.000297	0.0184	CrCbGaD
Lorazepam—Nausea—Irinotecan—breast cancer	0.000296	0.000391	CcSEcCtD
Lorazepam—Nausea—Mitoxantrone—breast cancer	0.000296	0.000391	CcSEcCtD
Lorazepam—Constipation—Docetaxel—breast cancer	0.000295	0.00039	CcSEcCtD
Lorazepam—Pain—Docetaxel—breast cancer	0.000295	0.00039	CcSEcCtD
Lorazepam—Chills—Epirubicin—breast cancer	0.000294	0.000388	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000292	0.00204	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000292	0.00204	CbGpPWpGaD
Lorazepam—Arrhythmia—Epirubicin—breast cancer	0.000292	0.000386	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—breast cancer	0.000292	0.000386	CcSEcCtD
Lorazepam—Asthenia—Paclitaxel—breast cancer	0.000292	0.000386	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ALDH1A1—breast cancer	0.00029	0.00203	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALDH7A1—breast cancer	0.00029	0.00203	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—COX11—breast cancer	0.00029	0.00203	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00029	0.00203	CbGpPWpGaD
Lorazepam—Quazepam—CYP3A4—breast cancer	0.000289	0.0179	CrCbGaD
Lorazepam—Alopecia—Epirubicin—breast cancer	0.000289	0.000382	CcSEcCtD
Lorazepam—Nausea—Gemcitabine—breast cancer	0.000289	0.000381	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Capecitabine—breast cancer	0.000288	0.000381	CcSEcCtD
Lorazepam—Fatigue—Capecitabine—breast cancer	0.000288	0.00038	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—breast cancer	0.000287	0.000379	CcSEcCtD
Lorazepam—Constipation—Capecitabine—breast cancer	0.000285	0.000377	CcSEcCtD
Lorazepam—Pain—Capecitabine—breast cancer	0.000285	0.000377	CcSEcCtD
Lorazepam—Erythema—Epirubicin—breast cancer	0.000285	0.000376	CcSEcCtD
Lorazepam—Diclofenac—ALB—breast cancer	0.000285	0.0176	CrCbGaD
Lorazepam—Feeling abnormal—Docetaxel—breast cancer	0.000284	0.000375	CcSEcCtD
Lorazepam—Nausea—Fluorouracil—breast cancer	0.000284	0.000375	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000282	0.00197	CbGpPWpGaD
Lorazepam—Tension—Epirubicin—breast cancer	0.00028	0.000369	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—UMPS—breast cancer	0.000278	0.00195	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PHGDH—breast cancer	0.000278	0.00195	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NME1—breast cancer	0.000278	0.00195	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FHL2—breast cancer	0.000278	0.00195	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ADSL—breast cancer	0.000278	0.00195	CbGpPWpGaD
Lorazepam—Nervousness—Epirubicin—breast cancer	0.000277	0.000366	CcSEcCtD
Lorazepam—Feeling abnormal—Capecitabine—breast cancer	0.000275	0.000363	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—breast cancer	0.000274	0.000361	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—HPSE—breast cancer	0.000273	0.00191	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LDHB—breast cancer	0.000273	0.00191	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—BRIP1—breast cancer	0.000273	0.00191	CbGpPWpGaD
Lorazepam—Chills—Doxorubicin—breast cancer	0.000272	0.000359	CcSEcCtD
Lorazepam—Diclofenac—ABCB1—breast cancer	0.000272	0.0168	CrCbGaD
Lorazepam—Arrhythmia—Doxorubicin—breast cancer	0.000271	0.000357	CcSEcCtD
Lorazepam—Clozapine—CYP1A1—breast cancer	0.000269	0.0167	CrCbGaD
Lorazepam—Dizziness—Paclitaxel—breast cancer	0.000269	0.000355	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—SPP1—breast cancer	0.000269	0.00188	CbGpPWpGaD
Lorazepam—Vision blurred—Epirubicin—breast cancer	0.000268	0.000355	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—breast cancer	0.000268	0.000354	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—ACHE—breast cancer	0.000267	0.00187	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—AR—breast cancer	0.000266	0.00186	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000266	0.00186	CbGpPWpGaD
Lorazepam—Convulsion—Methotrexate—breast cancer	0.000264	0.000349	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—breast cancer	0.000264	0.000348	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—ACHE—breast cancer	0.000262	0.00184	CbGpPWpGaD
Lorazepam—Agitation—Epirubicin—breast cancer	0.000262	0.000346	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BCHE—breast cancer	0.000261	0.00182	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA3—breast cancer	0.000259	0.00181	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMMR—breast cancer	0.000259	0.00181	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCC1—breast cancer	0.000259	0.00181	CbGpPWpGaD
Lorazepam—Tension—Doxorubicin—breast cancer	0.000259	0.000342	CcSEcCtD
Lorazepam—Vomiting—Paclitaxel—breast cancer	0.000259	0.000342	CcSEcCtD
Lorazepam—Rash—Paclitaxel—breast cancer	0.000256	0.000339	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000256	0.00179	CbGpPWpGaD
Lorazepam—Dermatitis—Paclitaxel—breast cancer	0.000256	0.000339	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—breast cancer	0.000256	0.000338	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—breast cancer	0.000256	0.000338	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000256	0.00179	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000256	0.00179	CbGpPWpGaD
Lorazepam—Estazolam—CYP3A4—breast cancer	0.000255	0.0158	CrCbGaD
Lorazepam—Headache—Paclitaxel—breast cancer	0.000255	0.000337	CcSEcCtD
Lorazepam—Hypersensitivity—Docetaxel—breast cancer	0.000254	0.000336	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000252	0.00176	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1B—breast cancer	0.000251	0.00175	CbGpPWpGaD
Lorazepam—Confusional state—Methotrexate—breast cancer	0.000251	0.000331	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—breast cancer	0.000248	0.000328	CcSEcCtD
Lorazepam—Asthenia—Docetaxel—breast cancer	0.000247	0.000327	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—breast cancer	0.000247	0.000326	CcSEcCtD
Lorazepam—Infection—Methotrexate—breast cancer	0.000247	0.000326	CcSEcCtD
Lorazepam—Nitrazepam—CYP3A4—breast cancer	0.000247	0.0153	CrCbGaD
Lorazepam—Hypertension—Epirubicin—breast cancer	0.000246	0.000325	CcSEcCtD
Lorazepam—Hypersensitivity—Capecitabine—breast cancer	0.000246	0.000325	CcSEcCtD
Lorazepam—Thrombocytopenia—Methotrexate—breast cancer	0.000243	0.000321	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—COMT—breast cancer	0.000243	0.0017	CbGpPWpGaD
Lorazepam—Agitation—Doxorubicin—breast cancer	0.000242	0.00032	CcSEcCtD
Lorazepam—Nausea—Paclitaxel—breast cancer	0.000242	0.000319	CcSEcCtD
Lorazepam—Asthenia—Capecitabine—breast cancer	0.000239	0.000316	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—COMT—breast cancer	0.000239	0.00167	CbGpPWpGaD
Lorazepam—Dry mouth—Epirubicin—breast cancer	0.000237	0.000313	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—breast cancer	0.000237	0.000313	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CA9—breast cancer	0.000237	0.00166	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA4—breast cancer	0.000237	0.00166	CbGpPWpGaD
Lorazepam—Prazepam—CYP3A4—breast cancer	0.000235	0.0146	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000234	0.00164	CbGpPWpGaD
Lorazepam—Confusional state—Epirubicin—breast cancer	0.000234	0.00031	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HES1—breast cancer	0.000234	0.00164	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BCHE—breast cancer	0.000233	0.00163	CbGpPWpGaD
Lorazepam—Hypotension—Methotrexate—breast cancer	0.000232	0.000307	CcSEcCtD
Lorazepam—Infection—Epirubicin—breast cancer	0.000231	0.000305	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GPX2—breast cancer	0.000231	0.00161	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA2—breast cancer	0.000231	0.00161	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.00023	0.00161	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—ACHE—breast cancer	0.000229	0.0016	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BCHE—breast cancer	0.000229	0.0016	CbGpPWpGaD
Lorazepam—Convulsion—Doxorubicin—breast cancer	0.000228	0.000302	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—breast cancer	0.000228	0.000301	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GPX4—breast cancer	0.000228	0.00159	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SULT1A1—breast cancer	0.000228	0.00159	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Epirubicin—breast cancer	0.000228	0.000301	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—breast cancer	0.000228	0.000301	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—breast cancer	0.000227	0.0003	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—IDH1—breast cancer	0.000223	0.00156	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA1—breast cancer	0.000223	0.00156	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NFKBIA—breast cancer	0.000222	0.00155	CbGpPWpGaD
Lorazepam—Somnolence—Methotrexate—breast cancer	0.000221	0.000292	CcSEcCtD
Lorazepam—Dizziness—Capecitabine—breast cancer	0.000221	0.000292	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—NAT2—breast cancer	0.00022	0.00154	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.00022	0.00154	CbGpPWpGaD
Lorazepam—Dry mouth—Doxorubicin—breast cancer	0.000219	0.00029	CcSEcCtD
Lorazepam—Flurazepam—CYP3A4—breast cancer	0.000219	0.0136	CrCbGaD
Lorazepam—Vomiting—Docetaxel—breast cancer	0.000219	0.00029	CcSEcCtD
Lorazepam—Triazolam—CYP3A4—breast cancer	0.000219	0.0136	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000218	0.00152	CbGpPWpGaD
Lorazepam—Rash—Docetaxel—breast cancer	0.000217	0.000287	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—breast cancer	0.000217	0.000287	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—breast cancer	0.000217	0.000287	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—breast cancer	0.000217	0.000287	CcSEcCtD
Lorazepam—Headache—Docetaxel—breast cancer	0.000216	0.000285	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—APC—breast cancer	0.000215	0.0015	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Methotrexate—breast cancer	0.000214	0.000283	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—breast cancer	0.000214	0.000283	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000214	0.0015	CbGpPWpGaD
Lorazepam—Infection—Doxorubicin—breast cancer	0.000214	0.000282	CcSEcCtD
Lorazepam—Pain—Methotrexate—breast cancer	0.000212	0.000281	CcSEcCtD
Lorazepam—Oxazepam—CYP3A4—breast cancer	0.000212	0.0131	CrCbGaD
Lorazepam—Vomiting—Capecitabine—breast cancer	0.000212	0.00028	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—breast cancer	0.000211	0.000278	CcSEcCtD
Lorazepam—Rash—Capecitabine—breast cancer	0.00021	0.000278	CcSEcCtD
Lorazepam—Dermatitis—Capecitabine—breast cancer	0.00021	0.000278	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—breast cancer	0.00021	0.000277	CcSEcCtD
Lorazepam—Temazepam—CYP3A4—breast cancer	0.00021	0.013	CrCbGaD
Lorazepam—Headache—Capecitabine—breast cancer	0.000209	0.000276	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—COMT—breast cancer	0.000209	0.00146	CbGpPWpGaD
Lorazepam—Somnolence—Epirubicin—breast cancer	0.000207	0.000273	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000206	0.00144	CbGpPWpGaD
Lorazepam—Nitrazepam—ABCB1—breast cancer	0.000205	0.0127	CrCbGaD
Lorazepam—Nausea—Docetaxel—breast cancer	0.000205	0.000271	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—breast cancer	0.000205	0.000271	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—FOS—breast cancer	0.000205	0.00143	CbGpPWpGaD
Lorazepam—Midazolam—CYP3A4—breast cancer	0.000203	0.0126	CrCbGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000203	0.00142	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000201	0.00141	CbGpPWpGaD
Lorazepam—Hypotension—Doxorubicin—breast cancer	0.000201	0.000266	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—breast cancer	0.000201	0.000265	CcSEcCtD
Lorazepam—Clozapine—CYP2D6—breast cancer	0.0002	0.0124	CrCbGaD
Lorazepam—Fatigue—Epirubicin—breast cancer	0.0002	0.000265	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—BCHE—breast cancer	0.0002	0.0014	CbGpPWpGaD
Lorazepam—Constipation—Epirubicin—breast cancer	0.000199	0.000263	CcSEcCtD
Lorazepam—Pain—Epirubicin—breast cancer	0.000199	0.000263	CcSEcCtD
Lorazepam—Nausea—Capecitabine—breast cancer	0.000198	0.000262	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000196	0.00137	CbGpPWpGaD
Lorazepam—Chlorprothixene—ABCB1—breast cancer	0.000195	0.0121	CrCbGaD
Lorazepam—UGT2B15—Metabolism—MED12—breast cancer	0.000193	0.00135	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DPYD—breast cancer	0.000193	0.00135	CbGpPWpGaD
Lorazepam—Feeling abnormal—Epirubicin—breast cancer	0.000192	0.000253	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—breast cancer	0.000191	0.000253	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ALDOA—breast cancer	0.00019	0.00133	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000187	0.00131	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—COMT—breast cancer	0.000186	0.0013	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000186	0.000245	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—breast cancer	0.000185	0.000245	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000185	0.0013	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOA3—breast cancer	0.000184	0.00129	CbGpPWpGaD
Lorazepam—Constipation—Doxorubicin—breast cancer	0.000184	0.000243	CcSEcCtD
Lorazepam—Pain—Doxorubicin—breast cancer	0.000184	0.000243	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SLC2A2—breast cancer	0.000183	0.00128	CbGpPWpGaD
Lorazepam—Hypersensitivity—Methotrexate—breast cancer	0.000183	0.000242	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—COMT—breast cancer	0.000183	0.00128	CbGpPWpGaD
Lorazepam—Flurazepam—ABCB1—breast cancer	0.000182	0.0113	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000182	0.00127	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CPT1A—breast cancer	0.000179	0.00125	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTR—breast cancer	0.000179	0.00125	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCG2—breast cancer	0.000179	0.00125	CbGpPWpGaD
Lorazepam—Asthenia—Methotrexate—breast cancer	0.000178	0.000236	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—breast cancer	0.000177	0.000234	CcSEcCtD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000177	0.00124	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HPGDS—breast cancer	0.000176	0.00123	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HBA1—breast cancer	0.000175	0.00122	CbGpPWpGaD
Lorazepam—Diazepam—CYP3A4—breast cancer	0.000174	0.0108	CrCbGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000173	0.00121	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000172	0.0012	CbGpPWpGaD
Lorazepam—Clozapine—CYP3A4—breast cancer	0.000172	0.0106	CrCbGaD
Lorazepam—Hypersensitivity—Epirubicin—breast cancer	0.000171	0.000226	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ACHE—breast cancer	0.000171	0.00119	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTT1—breast cancer	0.000171	0.00119	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.00017	0.00119	CbGpPWpGaD
Lorazepam—Midazolam—ABCB1—breast cancer	0.000169	0.0105	CrCbGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000169	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RAF1—breast cancer	0.000168	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RELA—breast cancer	0.000168	0.00117	CbGpPWpGaD
Lorazepam—Asthenia—Epirubicin—breast cancer	0.000167	0.00022	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—MTOR—breast cancer	0.000164	0.00115	CbGpPWpGaD
Lorazepam—Dizziness—Methotrexate—breast cancer	0.000164	0.000217	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYP17A1—breast cancer	0.000162	0.00113	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ENO1—breast cancer	0.00016	0.00112	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS1—breast cancer	0.00016	0.00112	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—COMT—breast cancer	0.00016	0.00112	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000159	0.00111	CbGpPWpGaD
Lorazepam—Hypersensitivity—Doxorubicin—breast cancer	0.000159	0.000209	CcSEcCtD
Lorazepam—Vomiting—Methotrexate—breast cancer	0.000158	0.000209	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYP2D6—breast cancer	0.000157	0.0011	CbGpPWpGaD
Lorazepam—Rash—Methotrexate—breast cancer	0.000157	0.000207	CcSEcCtD
Lorazepam—Dermatitis—Methotrexate—breast cancer	0.000157	0.000207	CcSEcCtD
Lorazepam—Headache—Methotrexate—breast cancer	0.000156	0.000206	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BRAF—breast cancer	0.000155	0.00108	CbGpPWpGaD
Lorazepam—Asthenia—Doxorubicin—breast cancer	0.000154	0.000204	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000154	0.00108	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOA2—breast cancer	0.000154	0.00108	CbGpPWpGaD
Lorazepam—Dizziness—Epirubicin—breast cancer	0.000154	0.000203	CcSEcCtD
Lorazepam—GABRB3—Ion channel transport—RAF1—breast cancer	0.000153	0.00107	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BRAF—breast cancer	0.000152	0.00106	CbGpPWpGaD
Lorazepam—Diazepam—ALB—breast cancer	0.000152	0.00941	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000151	0.00106	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—breast cancer	0.000151	0.00106	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000151	0.00106	CbGpPWpGaD
Lorazepam—GABRG2—Ion channel transport—RAF1—breast cancer	0.000151	0.00105	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FASN—breast cancer	0.000149	0.00104	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—BCHE—breast cancer	0.000149	0.00104	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000148	0.00104	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000148	0.00104	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000148	0.00103	CbGpPWpGaD
Lorazepam—Vomiting—Epirubicin—breast cancer	0.000148	0.000195	CcSEcCtD
Lorazepam—Nausea—Methotrexate—breast cancer	0.000148	0.000195	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—JUN—breast cancer	0.000147	0.00103	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC5A5—breast cancer	0.000147	0.00103	CbGpPWpGaD
Lorazepam—Rash—Epirubicin—breast cancer	0.000147	0.000194	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—breast cancer	0.000146	0.000194	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—CTNNB1—breast cancer	0.000146	0.00102	CbGpPWpGaD
Lorazepam—Headache—Epirubicin—breast cancer	0.000146	0.000192	CcSEcCtD
Lorazepam—Diazepam—ABCB1—breast cancer	0.000145	0.00898	CrCbGaD
Lorazepam—Clozapine—ABCB1—breast cancer	0.000143	0.00887	CrCbGaD
Lorazepam—Dizziness—Doxorubicin—breast cancer	0.000142	0.000188	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—NQO1—breast cancer	0.000142	0.000992	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC2A1—breast cancer	0.000142	0.000992	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK8—breast cancer	0.000139	0.000972	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP3A4—breast cancer	0.000138	0.000967	CbGpPWpGaD
Lorazepam—Nausea—Epirubicin—breast cancer	0.000138	0.000182	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—breast cancer	0.000137	0.000181	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYP1B1—breast cancer	0.000136	0.000951	CbGpPWpGaD
Lorazepam—Rash—Doxorubicin—breast cancer	0.000136	0.000179	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—breast cancer	0.000136	0.000179	CcSEcCtD
Lorazepam—Headache—Doxorubicin—breast cancer	0.000135	0.000178	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TFRC—breast cancer	0.000135	0.000942	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HSP90AA1—breast cancer	0.000133	0.000932	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000133	0.000931	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000132	0.000926	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000132	0.000925	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—SRC—breast cancer	0.000132	0.000921	CbGpPWpGaD
Lorazepam—GABRA1—Ion channel transport—RAF1—breast cancer	0.000132	0.00092	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MDM2—breast cancer	0.00013	0.000909	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOA1—breast cancer	0.00013	0.000907	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00013	0.000907	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00013	0.000906	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—RAF1—breast cancer	0.000129	0.000905	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—STK11—breast cancer	0.000128	0.000894	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP19A1—breast cancer	0.000128	0.000894	CbGpPWpGaD
Lorazepam—Nausea—Doxorubicin—breast cancer	0.000128	0.000169	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MDM2—breast cancer	0.000128	0.000892	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000127	0.00089	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000127	0.000889	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—RAF1—breast cancer	0.000127	0.000889	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—STAT3—breast cancer	0.000127	0.000888	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000124	0.000865	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000122	0.000853	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000122	0.000851	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000121	0.000849	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK3—breast cancer	0.000121	0.000849	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000119	0.000835	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COMT—breast cancer	0.000119	0.000831	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BRAF—breast cancer	0.000119	0.000831	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTP1—breast cancer	0.000118	0.000827	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—JUN—breast cancer	0.000118	0.000827	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000117	0.000821	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000117	0.00082	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BRAF—breast cancer	0.000117	0.000816	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMOX1—breast cancer	0.000117	0.000816	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ITPR1—breast cancer	0.000116	0.000814	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000116	0.000808	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCB1—breast cancer	0.000112	0.000783	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000112	0.00078	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000111	0.000778	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—RAF1—breast cancer	0.000111	0.000777	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TYMS—breast cancer	0.00011	0.000769	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000109	0.000764	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLA2G4A—breast cancer	0.000109	0.00076	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOR1—breast cancer	0.000109	0.00076	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM1—breast cancer	0.000109	0.00076	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000107	0.00075	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLG—breast cancer	0.000106	0.000744	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000106	0.000742	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLG—breast cancer	0.000105	0.000731	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX1—breast cancer	0.000104	0.000728	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000103	0.000722	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP1A1—breast cancer	0.000103	0.000721	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000103	0.000717	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ERCC2—breast cancer	0.000102	0.000715	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—BRAF—breast cancer	0.000102	0.000713	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MDM2—breast cancer	9.96e-05	0.000696	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—RAF1—breast cancer	9.92e-05	0.000694	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—breast cancer	9.82e-05	0.000687	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MDM2—breast cancer	9.78e-05	0.000684	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—RAF1—breast cancer	9.74e-05	0.000681	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—breast cancer	9.65e-05	0.000675	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—breast cancer	9.61e-05	0.000672	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	9.49e-05	0.000663	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—breast cancer	9.43e-05	0.000659	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—NCOA1—breast cancer	9.38e-05	0.000656	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	9.31e-05	0.000651	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—HRAS—breast cancer	9.27e-05	0.000648	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—breast cancer	9.26e-05	0.000647	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLG—breast cancer	9.14e-05	0.000639	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CAV1—breast cancer	8.86e-05	0.00062	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—breast cancer	8.86e-05	0.000619	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MDM2—breast cancer	8.55e-05	0.000598	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—RAF1—breast cancer	8.52e-05	0.000595	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—breast cancer	8.43e-05	0.00059	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—breast cancer	8.19e-05	0.000573	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.14e-05	0.000569	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—breast cancer	8.09e-05	0.000566	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CG—breast cancer	8.07e-05	0.000564	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—breast cancer	7.15e-05	0.0005	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—HRAS—breast cancer	7.13e-05	0.000499	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CD—breast cancer	7.1e-05	0.000496	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—breast cancer	7.01e-05	0.00049	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—HRAS—breast cancer	7e-05	0.00049	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NOS3—breast cancer	6.7e-05	0.000469	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CB—breast cancer	6.19e-05	0.000432	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—breast cancer	6.13e-05	0.000429	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—HRAS—breast cancer	6.12e-05	0.000428	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	5.9e-05	0.000412	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	5.79e-05	0.000405	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—HRAS—breast cancer	5.46e-05	0.000382	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—HRAS—breast cancer	5.37e-05	0.000375	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTEN—breast cancer	5.35e-05	0.000374	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	5.33e-05	0.000373	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	5.24e-05	0.000366	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	5.06e-05	0.000354	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—HRAS—breast cancer	4.69e-05	0.000328	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	4.58e-05	0.00032	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CA—breast cancer	3.77e-05	0.000264	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—breast cancer	3.08e-05	0.000215	CbGpPWpGaD
